WO1997003198A3 - Nucleotide and amino acid sequence and uses thereof - Google Patents
Nucleotide and amino acid sequence and uses thereof Download PDFInfo
- Publication number
- WO1997003198A3 WO1997003198A3 PCT/US1996/011320 US9611320W WO9703198A3 WO 1997003198 A3 WO1997003198 A3 WO 1997003198A3 US 9611320 W US9611320 W US 9611320W WO 9703198 A3 WO9703198 A3 WO 9703198A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid sequence
- amino acid
- nucleotide
- viral
- hydrophobic
- Prior art date
Links
- 125000003275 alpha amino acid group Chemical group 0.000 title abstract 2
- 239000002773 nucleotide Substances 0.000 title 1
- 125000003729 nucleotide group Chemical group 0.000 title 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 abstract 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 abstract 1
- 101710134686 Occlusion-derived virus envelope protein E66 Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 108010005774 beta-Galactosidase Proteins 0.000 abstract 1
- 102000005936 beta-Galactosidase Human genes 0.000 abstract 1
- 230000001086 cytosolic effect Effects 0.000 abstract 1
- -1 e.g. Proteins 0.000 abstract 1
- 239000005090 green fluorescent protein Substances 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 125000001165 hydrophobic group Chemical group 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 210000004779 membrane envelope Anatomy 0.000 abstract 1
- 210000004897 n-terminal region Anatomy 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8209—Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8221—Transit peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Cell Biology (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Immunology (AREA)
- Botany (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Abstract
The N-terminal region of 23 amino acids of ODV-E66 is composed predominantly of hydrophobic residues and was shown to be necessary and sufficient to target a cytoplasmic marker protein, e.g., beta-galactosidase, green fluorescent protein and URF13, to the intranuclear viral-induced unit-membranes and viral envelopes. The 23 hydrophobic amino acid sequence is (I).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU64838/96A AU6483896A (en) | 1995-07-07 | 1996-07-05 | Nucleotide and amino acid sequence and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95595P | 1995-07-07 | 1995-07-07 | |
US60/000,955 | 1995-07-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997003198A2 WO1997003198A2 (en) | 1997-01-30 |
WO1997003198A3 true WO1997003198A3 (en) | 1997-04-03 |
Family
ID=21693708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/011320 WO1997003198A2 (en) | 1995-07-07 | 1996-07-05 | Nucleotide and amino acid sequence and uses thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6483896A (en) |
WO (1) | WO1997003198A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7211659B2 (en) | 2001-07-05 | 2007-05-01 | Chiron Corporation | Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
US7282364B2 (en) | 2001-08-31 | 2007-10-16 | Novartis Vaccines And Diagnostics, Inc. | Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
US7348177B2 (en) | 1998-12-31 | 2008-03-25 | Novartis Vaccines And Diagnostics, Inc. | Expression of HIV polypeptides and production of virus-like particles |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3152297B2 (en) * | 1998-03-09 | 2001-04-03 | 日本電気株式会社 | PVC communication method |
DE19980721D2 (en) * | 1998-04-15 | 2001-03-29 | Wolfgang Bergter | CD4 radioimmunopharmaceuticals used to treat HIV infection |
EP1141314A2 (en) | 1998-12-31 | 2001-10-10 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
JP5977949B2 (en) * | 2011-01-31 | 2016-08-24 | 学校法人 愛知医科大学 | Degradation method for degrading chondroitin or chondroitin sulfate, method for producing highly sulfated oligosaccharide, and composition |
CN108456694A (en) * | 2017-02-22 | 2018-08-28 | 浙江和也健康科技有限公司 | A kind of genetic manipulation method and the application of fusion positioning system, electromagnetic induction system and target protein |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0505207A1 (en) * | 1991-03-22 | 1992-09-23 | Roussel Uclaf | Biological control agents |
-
1996
- 1996-07-05 WO PCT/US1996/011320 patent/WO1997003198A2/en active Application Filing
- 1996-07-05 AU AU64838/96A patent/AU6483896A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0505207A1 (en) * | 1991-03-22 | 1992-09-23 | Roussel Uclaf | Biological control agents |
Non-Patent Citations (4)
Title |
---|
BRAUNAGEL S C ET AL: "Autographa californica nuclear polyhedrosis virus, PDV, and ECV viral envelopes and nucleocapsids: Structural proteins, antigens, lipid and fatty acid profiles", VIROLOGY, 202 (1). 1994. 315-328., XP002025638 * |
HONG T ET AL: "Transcription, Translation, and Cellular Localization of PDV-E66: A Structural Protein of the PDV Envelope of Autographa californica Nuclear Polyhedrosis Virus", VIROLOGY, 204 (1). 1994. 210-222., XP002025636 * |
JARVIS D L ET AL: "REQUIREMENTS FOR NUCLEAR LOCALIZATION AND SUPRAMOLECULAR ASSEMBLY OF A BACULOVIRUS POLYHEDRIN PROTEIN", VIROLOGY, 185 (2). 1991. 795-810., XP000609355 * |
OOMENS A G P ET AL: "The baculovirus GP64 envelope fusion protein: Synthesis, oligomerization, and processing", VIROLOGY, 209 (2). 1995. 592-603., XP002025639 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7348177B2 (en) | 1998-12-31 | 2008-03-25 | Novartis Vaccines And Diagnostics, Inc. | Expression of HIV polypeptides and production of virus-like particles |
US7211659B2 (en) | 2001-07-05 | 2007-05-01 | Chiron Corporation | Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
US9598469B2 (en) | 2001-07-05 | 2017-03-21 | Novartis Vaccines And Diagnostics, Inc. | HIV-1 south african subtype C env proteins |
US7282364B2 (en) | 2001-08-31 | 2007-10-16 | Novartis Vaccines And Diagnostics, Inc. | Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
AU6483896A (en) | 1997-02-10 |
WO1997003198A2 (en) | 1997-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000023472A3 (en) | Interferon-beta fusion proteins and uses | |
CA2089094A1 (en) | Expression of recombinant polypeptides with improved purification | |
AU5332290A (en) | Computer-assisted design of anti-peptides based on the amino acid sequence of a target peptide | |
EP0307592A3 (en) | Analogues of the pancreatic bovine trypsin inhibitor, their production and use | |
EP0728764A4 (en) | Peptide capable of inducing immune response against hiv and aids preventive or remedy containing the peptide | |
EP2011510A3 (en) | Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments | |
WO1998055508A3 (en) | HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS | |
IL205233A0 (en) | A polypeptide comprising the amino acid sequence of osteoprotegerin from residues 22 to 401 inclusive, or a fragment or trunaction thereof | |
AU1552599A (en) | Novel peptide, apoep1.b, compositions and uses thereof | |
EP1420821B8 (en) | Immunologically significant herpes simplex virus antigens and methods for using same | |
EP0962531A3 (en) | Interferon-gamma production inducing isolated polypeptide fragment and an isolated DNA fragment encoding said polypeptide | |
AU1353295A (en) | Peptides derived from a retrovirus of the HIV group, and their use | |
WO1999050282A3 (en) | Peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases | |
WO1997003198A3 (en) | Nucleotide and amino acid sequence and uses thereof | |
WO2001025438A3 (en) | Ifn-alpha homologues | |
CA2303061A1 (en) | Lunasin peptides | |
EP0161007A3 (en) | Retro - inverso c-terminal hexapeptide analogues of substance p | |
AU7758598A (en) | Stable pharmaceutical administration forms of peptides, proteins and nucleic acids | |
CA2096532A1 (en) | New human recombinant gamma-interferon | |
AU4120096A (en) | Production of recombinant peptides as natural hydrophobic peptide analogues | |
WO2000018909A3 (en) | NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM) | |
AU2511901A (en) | Basolateral sorting signal and inhibitors thereof | |
IE883545L (en) | Peptide structures, immunogens containing them and their uses in the control of fertility | |
EP0770875A3 (en) | Marker and reagent for diabetes mellitus and diabetes mellitus complication | |
WO1999022005A3 (en) | Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |